Skip to content

Use of tramadol in dental injections for numbness on teeth

Use of tramadol injections on the anaesthetic success rate of intraligamentary injections in patients with symptomatic irreversible pulpitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046240
Enrollment
100
Registered
2022-10-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K040- Pulpitis

Interventions

Intervention1: intraligamentary injections of tramadol hydrochloride: The injections will be administered using a pressure-type syringe (Osung Deosy, Pearland, Tx, USA) and 30 gauge short needles (Sep

Sponsors

Jamia Millia Islamia
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria: a. Symptomatic carious exposed mandibular first or second molars. b. Positive and prolonged response to thermal sensitivity tests and electric pulp test. c. Vital coronal pulp on access cavity preparation. d. American Society of Anesthesiologists class I or II medical history. e. Ability to understand the use of pain scales.

Exclusion criteria

Exclusion criteria: Exclusion criteria a. Active pain in more than 1 tooth. b. Teeth with fused roots. c. Radiographic evidence of an extra root. d. Large restorations with overhanging margins. e. Full crowns or deep periodontal pockets. f. Known allergy or contraindications to any content of the local anaesthetic solution. g. History of known or suspected drug abuse. h. Taking any drugs which could affect the pain perception, e.g, opioids, antidepressants, anticonvulsants, muscle relaxants, anxiolytics, sedatives, NSAIDs. i. Pregnant or breastfeeding patients.

Design outcomes

Primary

MeasureTime frame
Anesthetic success during endodontic proceduresTimepoint: 10 Minutes after inytaligamentary injections

Secondary

MeasureTime frame
Measurements of heart ratesTimepoint: 5 minutes after injections

Countries

India

Contacts

Public ContactVivek Aggarwal

Jamia Millia Islamia

drvivekaggarwal@gmail.com9818188358

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026